Skip to Main Content
  • MyChart
  • Pay a Bill
  • Help
St. Luke’s Logo to Homepage
  1. Home
  2. Get Care
  3. Providers
  4. Christopher M. Wanjiku, MD
  1. ProvidersProviders
Christopher Wanjiku, MD

Christopher M. Wanjiku, MD

  • Medical Oncology
St. Luke’s Clinic Provider

St. Luke’s Clinic Provider

  • Accepting New Patients

  • About
  • Locations

About Christopher M. Wanjiku, MD

Christopher Wanjiku, MD has a special interest in malignant hematology and cellular therapy. He is passionate about making treatment for these diseases accessible and acceptable to patients. He has been extensively involved in caring for patients with multiple myeloma, acute leukemias and other hematologic conditions. He has participated in research involving caring for older adults with acute myeloid leukemia, standard follow-up assessments for post-transplant patients and optimizing tele-oncol...

Education

Medical School

University of Nairobi

Residency

Duke University Medical Center

Fellowship

University of North Carolina School of Medicine

Board Certification

  • Internal Medicine

Awards and Distinctions

  • 2021
    Hematology Resident Trainee Award, American Society of Hematology

    2019
    The Global Showcase Award, American Society of Hematology

    2016
    The Young Investigator Award, World Federation of Hemophilia

Publications

  • 2026
    Caring for Older Adults with Acute Myeloid Leukemia: Best Practices for Aligning Patient Fitness and Preference with Available Therapies. Drugs & Aging.

    2025
    Assessing Quality of Life and Symptoms in Transplantation and CAR-T Recipients: Expert Panel Recommendations from the Survivorship Special Interest Group of ASTC. Transplant and cell therapy.

    2025
    Effectiveness of second-line therapies following upfront daratumumab plus bortezomib, cyclophosphamide and dexamethasone: A new benchmark. ASH Blood.

    2022
    Acute Myeloid Leukemia in Western Kenya: Exploring Outcome Disparities through Cases. ASH Blood.

    2018
    Equitable Access to Gene Therapy: A Call to Action for the American Society of Gene and Cell Therapy. Molecular Therapy.

Provider Locations

  • Primary Location
    St. Luke’s Cancer Institute - Center for Blood Cancer Therapy: Boise

    100 E. Idaho St., Suite 200, Boise, ID 83712
    (208) 381-2711
    Mon - Fri: 7:30 a.m. - 5 p.m.
    Location details
    Exterior view of St. Luke’s Cancer Institute: Boise where St. Luke’s Cancer Institute – Center for Blood Cancer Therapy: Boise is located
St. Luke’s Homepage

About St. Luke’s

Who We Are
News
Careers

Team Resources

For Providers
For Employees
For Contractors

Patient Resources

Financial Assistance
Mental Health Support
Medical Records
Patient Rights & Responsibilities

Essential Information

Accessibility
Price Transparency
En Español

Quick Links

Contact Us
St. Luke’s FitOne
St. Luke’s Health Network
St. Luke’s Health Plan

DisclaimerNon-Discrimination/EEOPrivacy PracticesTerms of Use
© 2026 St. Luke’s Health System. All rights reserved.
FacebookLinkedinYoutubeInstagram